PT-141 (Bremelanotide)

Melanocortin receptor agonist

Bremelanotide acts through melanocortin pathways and has an FDA-approved product for a specific sexual-health indication in eligible premenopausal women. Other uses are not equivalent to that approval.

Book consultation (845) 285-1633

Treatment details

What’s included

Clinical consultation, medical-history and medication review, eligibility assessment, discussion of regulatory status and alternatives, and ongoing monitoring when appropriate.

Clinical & Availability Review

Office: 2874 Route 94, Washingtonville, NY 10992

Appointments

Monday through Saturday from 1:00 PM to 6:00 PM.

Mobile infusion appointments are available Monday through Saturday from 9:00 AM to 8:00 PM.

Continue to booking PAYMENTS PLANS AVAILABLE

Explore more

Related peptide options

Clinical Review

GHK-Cu

GHK-Cu is a naturally occurring copper-binding peptide studied in skin, hair, collagen, and tissue-repair contexts...

View option